Life Sciences External Ecosystem Stakeholders and Engagement Practices

Part
01
of two
Part
01

External Factors Impacting New Oncology Products

Two of the biggest external factors impacting new oncology pharmaceutical products coming onto the market are pricing and legalities. Below is an overview of the findings on this subject matter.

EXTERNAL FACTORS IMPACTING NEW ONCOLOGY PRODUCTS

PRICING

LEGALITIES

  • Biosimilars are facing lawsuits over biologic patents, which is affecting its growth rate on the market.
  • Companies have to engage in expensive clinical trials before they can enter the market.
  • New products also require prior authorizations.
  • Legislation is being put in place to control pricing at the state and federal level and California is leading in this area.
  • There is legislation, regulations, and advocacy that companies must adhere to in order to market and advertise their products to consumers, strongly supported by the American Medical Association.
  • President Donald Trump, in a State of the Union Address, shed light on a policy that allows patients who are terminally ill to access unapproved drugs through the right-to-try legislation. This could pose a challenge for companies that are producing new products in the same area as patients could be less interested in their products if they are offered at high prices.
  • It also reduces the number of patients who would once be interested in clinical trials.
  • New products that are supported by the American Society of Clinical Oncology (ASCO) are likely to see an increase in use.

Research Strategy

For this research, we defined the biggest external factors as the most talked about issues that companies with new oncology pharmaceutical products are facing as described in research, news, industry reports, market trend reports, consulting and blogs. We used sources such as NAP, Gentech Forum, Blue Matter Consulting, Pro Clinical Blog and Biologics Inc. to answer the question. The selected external factors appeared a minimum of six times across sources which are all in the U.S. market for oncology pharmaceutical products.


Part
02
of two
Part
02

Pharmaceutical Workshops

Three examples of pharmaceutical workshops include; Strategy and Planning for Commercial Launch Success in Pharma, Global Pharmaceutical and Pharma Industry Conference, and the 3rd Global Pharmaceutical Conference and Expo.

1. Strategy and Planning for Commercial Launch Success in Pharma

  • The key topics presented included; critical success factors of a commercial drug launch, structured road map of the launch process in major therapy areas of oncology immunotherapy, immunology, CNS, CVS and metabolic disorders, market and customer insights, use of the patient journey and leverage points, omnichannel design and launch strategy, and review of best practices.
  • The presentations included face-to-face forums with pharma experts, interactive lectures, case studies, group exercises, and discussions with international peers.
  • The two-day workshop was delivered by Kurt Arco and Dr. Joeri De Haes.
  • The next event is scheduled from 25th to 26th June 2019 in London.
  • Past delegates have rated the event 8.7/10 based on recommendations scores.

2. Global Pharmaceutical and Pharma Industry Conference

  • This is an international pharmaceutical and pharma industry conference. The key topics presented included; bio-pharmaceutics, pharmaceutical chemistry, drug targeting and design, pharmacokinetics and pharmacodynamics in drugs, pharmaceutical formulation, manufacturing, nanotechnology, drug and vaccine delivery systems, nanomedicine and biomedical applications, bio materials in drug delivery, biosimilars, pharmaceutical analysis, process validation, packaging, clinical trials, pharmacogenetics and genomics, regulatory affairs, pharmacovigilance, and market analysis.
  • The presentations were delivered through keynote presentations, oral talks, poster presentations, symposia, workshops, exhibitions, career programs, and B2B meetings.
  • The last workshop was held from February 28-March 01, 2019 at Osaka, Japan, and lasted three days.
  • The workshop had over 200 participants, 70% of whom were leaders in the pharma industry and 30% academia field.

3. The 3rd Global Pharmaceutical Conference and Expo

  • The annual i- Pharma workshop is organized by the ipharma group for pharma and healthcare professionals in the UK and Europe. Key topics presented include; drug design, therapy and discovery, digital pharma and multichannel marketing, innovative drug delivery systems, big data and analytics for pharma, pharmaceutical microbiology, pharmacovigilance, regulatory affairs and clinical trials, cosmeceuticals, orphan drugs, pharmaceutical nanotechnology, pharmaceutical manufacturing operations, pharma packaging, biosimilars, neuropharmacology, biopharmaceuticals, and nutra- pharma integration.
  • Presentations were delivered through workshops, symposiums, plenary sessions, key pharma leaders and company’s insights, interactive panel sessions, and peer discussions.
  • The event lasted three days. The next event is scheduled for July 03-05, 2019, London, UK.

Sources
Sources

From Part 02
Quotes
  • "The course content builds on the expertise and experience that the experts have accumulated over the last 15 years in advising and implementing major product launches in EMEA across major therapy areas: Oncology (incl. Immunotherapy), Immunology, CNS, CVS and Metabolic Disorders. It covers all concepts and evidence-based tools for effective strategic decision- making and planning in the process up to launch, with a focus on what will determine the brand’s commercial success."
Quotes
  • "The annual i- Pharma conference and expo 2019 is the largest gathering of Pharma and Healthcare professionals in UK and in Europe. i- Pharma UK is expecting hundreds of academic, research and industry leaders from 24 different countries to gather in London, UK for this three day meeting. i- Pharma Congress 2019 is packed with many workshops, symposiums and multiple plenary sessions with main focus on thought provoking discussions and peer led networking. The conference is the ideal venue for to learn about the latest trends shaping the pharma industry, to gain new skills and insights from successful pharma experts."
Quotes
  • "Global Pharmaceutica 2019 covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Pharmaceutical Manufacturing, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Nanomedicine and Biomedical Applications, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacogenetics and Genomics, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Drug Safety, Pharmacy Education and Practice"